— Know what they know.
Not Investment Advice

TNDM

Tandem Diabetes Care, Inc.
1W: +1.7% 1M: -9.8% 3M: +4.3% YTD: +12.6% 1Y: +17.6% 3Y: -41.7% 5Y: -71.0%
$24.26
-0.25 (-1.02%)
After Hours: $21.77 (-2.49, -10.24%)
NASDAQ · Healthcare · Medical - Devices · $1.7B · Alpha Radar Neutral · Power 48
Smart Money Score
Moderate 50
Insider+$0.0M
Congress
ETF Holdings
Key Statistics
Market Cap$1.7B
52W Range9.98-29.65
Volume1,212,913
Avg Volume1,920,627
Beta1.67
Dividend
Analyst Ratings
24 Buy 15 Hold 0 Sell
Consensus Buy
Company Info
CEOJohn F. Sheridan
Employees2,650
SectorHealthcare
IndustryMedical - Devices
IPO Date2013-11-14
11075 Roselle Street
San Diego, CA 92121
US
858 366 6900
About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Recent Insider Trades

NameTypeSharesPriceDate
Novara Mark David S-Sale 187 $23.05 2026-03-17
Novara Mark David M-Exempt 7,414 2026-03-16
Novara Mark David F-InKind 5,540 $21.59 2026-03-16
Novara Mark David M-Exempt 7,414 2026-03-16
Novara Mark David S-Sale 2 $22.81 2026-03-05

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms